Feng Chi Biotech Corp. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was TWD 99.863 million compared to TWD 91.869 million a year ago. Operating income was TWD 17.180 million compared to TWD 9.227 million a year ago. Net income was TWD 14.912 million compared to TWD 8.347 million a year ago. Basic earnings per share was TWD 0.97 compared to TWD 0.57 a year ago.